Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia

Seminars in Oncology

Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 44-51

  Waselenko, J K ^a   Grever, M R ^a   Beer, M ^a   Lucas, M A ^a   Byrd, J C ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ALKYLATING AGENT; CHLORAMBUCIL; CLOTRIMAZOLE; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC ACTIVITY; B CELL LEUKEMIA; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNE DEFICIENCY; NEUTROPENIA; OPPORTUNISTIC INFECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHLORAMBUCIL; CLINICAL TRIALS, PHASE II; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PENTOSTATIN; REMISSION INDUCTION; VIDARABINE;

EID: 0033946545     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)